Progression to chronic kidney disease in patients undergoing nephrectomy for small renal masses: a price to pay for a therapeutic success?

References

• Glassock RJ, Warnock DG, Delanaye P. The global burden of chronic kidney disease: estimates, variability and pitfalls. Nat Rev Nephrol. 2017;13:104–114.
   PubMed Web of Science ®Google Scholar
• Thomas R, Kanso A, Sedor JR. Chronic kidney disease and its complications. Prim Care. 2008;35:329–344. vii.
   PubMed Web of Science ®Google Scholar
• Tonelli M, Riella MC. Chronic kidney disease and the aging population. Kidney Int. 2014;85:487–491.
   PubMed Web of Science ®Google Scholar
• Webster AC, Nagler EV, Morton RL, et al. Chronic kidney disease. Lancet. 2017;389:1238–1252.
   PubMed Web of Science ®Google Scholar
• Jha V, Garcia-Garcia G, Iseki K, et al. Chronic kidney disease: global dimension and perspectives. Lancet. 2013;382:260–272.
   PubMed Web of Science ®Google Scholar
• Levey AS, Astor BC, Stevens LA, et al. Chronic kidney disease, diabetes, and hypertension: what’s in a name? Kidney Int. 2010;78:19–22.
   PubMed Web of Science ®Google Scholar
• Siegel RL, Miller KD, Jemal A. Cancer statistics, 2018. CA Cancer J Clin. 2018;68:7–30.
   PubMed Web of Science ®Google Scholar
• Janzen NK, Kim HL, Figlin RA, et al. Surveillance after radical or partial nephrectomy for localized renal cell carcinoma and management of recurrent disease. Urol Clin North Am. 2003;30:843–852.
   PubMed Web of Science ®Google Scholar
• Provet J, Tessler A, Brown J, et al. Partial nephrectomy for renal cell carcinoma: indications, results and implications. J Urol. 1991;145:472–476.
   PubMed Web of Science ®Google Scholar
• Russo P, Huang W. The medical and oncological rationale for partial nephrectomy for the treatment of T1 renal cortical tumors. Urol Clin North Am. 2008;35:635–643.
   PubMed Web of Science ®Google Scholar
• Zabor EC, Furberg H, Mashni J, et al. Factors associated with recovery of renal function following radical nephrectomy for kidney neoplasms. Clin J Am Soc Nephrol. 2016;11:101–107.
   PubMed Web of Science ®Google Scholar
• Zabor EC, Furberg H, Lee B, et al. Long-term renal function recovery following radical nephrectomy for kidney cancer: results from a . J Urol. 2018;199:921–926.
   PubMed Web of Science ®Google Scholar
• Winer AG, Zabor EC, Vacchio MJ, et al. The effect of patient and surgical characteristics on renal function after partial nephrectomy. Clin Genitourin Cancer. 2018;16:191–196.
   PubMed Web of Science ®Google Scholar
• EAU Guidelines. Edn. Presented at the EAU Annual Congress Copenhagen, Denmark; 2018. ISBN 978–94–92671–01–1.
   Google Scholar
• Campbell SC, Novick AC, Belldegrun A, et al. Guideline for management of the clinical T1 renal mass. J Urol. 2009;182:1271–1279.
   PubMed Web of Science ®Google Scholar
• Thompson RH, Siddiqui S, Lohse CM, et al. Partial versus radical nephrectomy for 4 to 7 cm renal cortical tumors. J Urol. 2009;182:2601–2606.
   PubMed Web of Science ®Google Scholar
• Feifer A, Savage C, Rayala H, et al. Prognostic impact of muscular venous branch invasion in localized renal cell carcinoma cases. J Urol. 2011;185:37–42.
   PubMed Web of Science ®Google Scholar
• MacLennan S, Imamura M, Lapitan MC, et al. Systematic review of perioperative and quality-of-life outcomes following surgical management of localised renal cancer. Eur Urol. 2012;62:1097–1117.
   PubMed Web of Science ®Google Scholar
• Malyszko J, Kozlowski L, Kozlowska K, et al. Cancer and the kidney: dangereoux liasons or price paid for the progress in medicine? Oncotarget. 2017;8:66601–66619.
   PubMed Web of Science ®Google Scholar
• Miller DC, Schonlau M, Litwin MS, et al. Renal and cardiovascular morbidity after partial or radical nephrectomy. Cancer. 2008;112:511–520.
   PubMed Web of Science ®Google Scholar
• Huang WC, Levey AS, Serio AM, et al. Chronic kidney disease after nephrectomy in patients with renal cortical tumours: a retrospective cohort study. Lancet Oncol. 2006;7:735–740.
   PubMed Web of Science ®Google Scholar
• Kong HJ, Park JS, Kim DY, et al. Renal function following curative surgery for renal cell carcinoma: who is at risk for renal insufficiency? Korean J Urol. 2013;54:830–833.
   PubMedGoogle Scholar
• Sun M, Bianchi M, Hansen J, et al. Chronic kidney disease after nephrectomy in patients with small renal masses: a retrospective observational analysis. Eur Urol. 2012;62:696–703.
   PubMed Web of Science ®Google Scholar
• Stevens LA, Coresh J, Greene T, et al. Assessing kidney function–measured and estimated glomerular filtration rate. N Engl J Med. 2006;354:2473–2483.
   PubMed Web of Science ®Google Scholar
• Patel SS, Molnar MZ, Tayek JA, et al. Serum creatinine as a marker of muscle mass in chronic kidney disease: results of a cross-sectional study and review of literature. J Cachexia Sarcopenia Muscle. 2013;4:19–29.
   PubMed Web of Science ®Google Scholar
• Knight EL, Verhave JC, Spiegelman D, et al. Factors influencing serum cystatin C levels other than renal function and the impact on renal function measurement. Kidney Int. 2004;65:1416–1421.
   PubMed Web of Science ®Google Scholar
• Rahman M, Smith MC. Chronic renal insufficiency: a diagnostic and therapeutic approach. Arch Intern Med. 1998;158:1743–1752.
   PubMedGoogle Scholar
• Hoste L, Deiteren K, Pottel H, et al. Routine serum creatinine measurements: how well do we perform? BMC Nephrol. 2015;16:21.
   PubMed Web of Science ®Google Scholar
• Antonucci E, Lippi G, Ticinesi A, et al. Neutrophil gelatinase-associated lipocalin (NGAL): a promising biomarker for the early diagnosis of acute kidney injury (AKI). Acta Biomed. 2014;85:289–294.
   PubMedGoogle Scholar
• Basturk T, Sari O, Koc Y, et al. Prognostic significance of NGAL in early stage chronic kidney disease. Minerva Urol Nefrol. 2017;69:307–312.
   PubMed Web of Science ®Google Scholar
• Isakova T, Wahl P, Vargas GS, et al. Fibroblast growth factor 23 is elevated before parathyroid hormone and phosphate in chronic kidney disease. Kidney Int. 2011;79:1370–1378.
   PubMed Web of Science ®Google Scholar
• Gutierrez O, Isakova T, Rhee E, et al. Fibroblast growth factor-23 mitigates hyperphosphatemia but accentuates calcitriol deficiency in chronic kidney disease. J Am Soc Nephrol. 2005;16:2205–2215.
   PubMed Web of Science ®Google Scholar
• Wasung ME, Chawla LS, Madero M. Biomarkers of renal function, which and when? Clin Chim Acta. 2015;438:350–357.
   PubMed Web of Science ®Google Scholar
• Sejima T, Yumioka T, Yamaguchi N, et al. Comprehensive analysis of factors affecting post-partial nephrectomy renal global function. Yonago Acta Med. 2017;60:94–100.
   PubMed Web of Science ®Google Scholar
• Sejima T, Honda M, Takenaka A. Renal parenchymal histopathology predicts life-threatening chronic kidney disease as a result of radical nephrectomy. Int J Urol. 2015;22:14–21.
   PubMed Web of Science ®Google Scholar
• Choi SK, Song C. Risk of chronic kidney disease after nephrectomy for renal cell carcinoma. Korean J Urol. 2014;55:636–642.
   PubMedGoogle Scholar
• Muramaki M, Miyake H, Sakai I, et al. Prognostic factors influencing postoperative development of chronic kidney disease in patients with small renal tumors who underwent partial nephrectomy. Curr Urol. 2013;6:129–135.
   PubMedGoogle Scholar
• Trevisani F, Ghidini M, Larcher A, et al. MicroRNA 193b-3p as a predictive biomarker of chronic kidney disease in patients undergoing radical nephrectomy for renal cell carcinoma. Br J Cancer. 2016;115:1343–1350.
   PubMed Web of Science ®Google Scholar
• Frees SK, Mager R, Borgmann H, et al. Standardoperationen bei kleinen Nierentumoren (<4 cm). Urologe. 2018;57:280–284.
   PubMed Web of Science ®Google Scholar
• Fehrman-Ekholm I, Duner F, Brink B, et al. No evidence of accelerated loss of kidney function in living kidney donors: results from a cross-sectional follow-up. Transplantation. 2001;72:444–449. https://www.ncbi.nlm.nih.gov/pubmed/11502974
   PubMed Web of Science ®Google Scholar
• Najarian JS, Chavers BM, McHugh LE, et al. 20 years or more of follow-up of living kidney donors. Lancet. 1992;340:807–810.
   PubMed Web of Science ®Google Scholar
• Kriegmair MC, Wagener N, Diehl SJ, et al. Ablative Therapien kleiner Nierentumoren. Urologe. 2018;57:285–294.
   PubMed Web of Science ®Google Scholar
• Ginzburg S, Tomaszewski JJ, Kutikov A. Focal ablation therapy for renal cancer in the era of active surveillance and minimally invasive partial nephrectomy. Nat Rev Urol. 2017;14:669–682.
   PubMed Web of Science ®Google Scholar
• Robson CJ, Churchill BM, Anderson W. The results of radical nephrectomy for renal cell carcinoma. J Urol. 1969;101:297–301.
   PubMed Web of Science ®Google Scholar
• Donat SM, Diaz M, Bishoff JT, et al. Follow-up for clinically localized renal neoplasms: AUA guideline. J Urol. 2013;190:407–416.
   PubMed Web of Science ®Google Scholar
• Li L, Lau WL, Rhee CM, et al. Risk of chronic kidney disease after cancer nephrectomy. Nat Rev Nephrol. 2014;10:135–145.
   PubMed Web of Science ®Google Scholar
• Campbell S, Uzzo RG, Allaf ME, et al. Renal mass and localized renal cancer: AUA guideline. J Urol. 2017;198:520–529.
   PubMed Web of Science ®Google Scholar
• Finelli A, Ismaila N, Bro B, et al. Management of small renal masses: American society of clinical oncology clinical practice guideline. J Clin Oncol. 2017;13:276–278.
   Google Scholar
• Hamilton ZA, Uzzo RG, Larcher A, et al. Comparison of functional outcomes of robotic and open partial nephrectomy in patients with pre-existing chronic kidney disease: a multicenter study. World J Urol. 2018;36:1255–1262.
   PubMed Web of Science ®Google Scholar
• Chang KD, Abdel Raheem A, Kim KH, et al. Functional and oncological outcomes of open, laparoscopic and robot-assisted partial nephrectomy: a multicentre comparative matched-pair analyses with a median of 5 years’ follow-up. BJU Int. 2018 Apr 12. doi: 10.1111/bju.14245. [Epub ahead of print].
   Web of Science ®Google Scholar
• Lee BR, Tan BJ, Smith AD. Laparoscopic port site metastases: incidence, risk factors, and potential preventive measures. Urology. 2005;65:639–644.
   PubMed Web of Science ®Google Scholar
• Song J, Kim E, Mobley J, et al. Port site metastasis after surgery for renal cell carcinoma: harbinger of future metastasis. J Urol. 2014;192:364–368.
   PubMed Web of Science ®Google Scholar
• Chang A, Finelli A, Berns JS, et al. Chronic kidney disease in patients with renal cell carcinoma. Adv Chronic Kidney Dis. 2014;21:91–95.
   PubMed Web of Science ®Google Scholar
• Van Poppel H, Da Pozzo L, Albrecht W, et al. A prospective randomized EORTC intergroup phase 3 study comparing the complications of elective nephron-sparing surgery and radical nephrectomy for low-stage renal cell carcinoma. Eur Urol. 2007;51:1606–1615.
   PubMed Web of Science ®Google Scholar
• Simhan J, Smaldone MC, Tsai KJ, et al. Objective measures of renal mass anatomic complexity predict rates of major complications following partial nephrectomy. Eur Urol. 2011;60:724–730.
   PubMed Web of Science ®Google Scholar
• Kazancioglu R. Risk factors for chronic kidney disease: an update. Kidney Int Suppl. 2013;3:368–371.
   PubMed Web of Science ®Google Scholar
• Isharwal S, Ye W, Wang A, et al. Impact of comorbidities on functional recovery from partial nephrectomy. J Urol. 2018;199:1433–1439.
   PubMed Web of Science ®Google Scholar
• Zhang Z, Zhao J, Zabell J, et al. Proteinuria in patients undergoing renal cancer surgery: impact on overall survival and stability of renal function. Eur Urol Focus. 2016;2:616–622.
   PubMedGoogle Scholar
• Thompson RH, Lane BR, Lohse CM, et al. Renal function after partial nephrectomy: effect of warm ischemia relative to quantity and quality of preserved kidney. Urology. 2012;79:356–360.
   PubMed Web of Science ®Google Scholar
• Pouliot F, Pantuck A, Imbeault A, et al. Multivariate analysis of the factors involved in loss of renal differential function after laparoscopic partial nephrectomy: a role for warm ischemia time. Can Urol Assoc J. 2011;5:89–95.
   PubMed Web of Science ®Google Scholar
• Funahashi Y, Hattori R, Yamamoto T, et al. Ischemic renal damage after nephron-sparing surgery in patients with normal contralateral kidney. Eur Urol. 2009;55:209–215.
   PubMed Web of Science ®Google Scholar
• Lane BR, Fergany AF, Weight CJ, et al. Renal functional outcomes after partial nephrectomy with extended ischemic intervals are better than after radical nephrectomy. J Urol. 2010;184:1286–1290.
   PubMed Web of Science ®Google Scholar
• Lane BR, Russo P, Uzzo RG, et al. Comparison of cold and warm ischemia during partial nephrectomy in 660 solitary kidneys reveals predominant role of nonmodifiable factors in determining ultimate renal function. J Urol. 2011;185:421–427.
   PubMed Web of Science ®Google Scholar
• Rod X, Peyronnet B, Seisen T, et al. Impact of ischaemia time on renal function after partial nephrectomy: a systematic review. BJU Int. 2016;118:692–705.
   PubMed Web of Science ®Google Scholar
• Mir MC, Campbell RA, Sharma N, et al. Parenchymal volume preservation and ischemia during partial nephrectomy: functional and volumetric analysis. Urology. 2013;82:263–268.
   PubMed Web of Science ®Google Scholar
• Funahashi Y, Yoshino Y, Sassa N, et al. Comparison of warm and cold ischemia on renal function after partial nephrectomy. Urology. 2014;84:1408–1412.
   PubMed Web of Science ®Google Scholar
• Aboumarzouk OM, Stein RJ, Eyraud R, et al. Robotic versus laparoscopic partial nephrectomy: a systematic review and meta-analysis. Eur Urol. 2012;62:1023–1033.
   PubMed Web of Science ®Google Scholar
• Bertolo R, Garisto J, Dagenais J, et al. Cold versus warm ischemia robot-assisted partial nephrectomy: comparison of functional outcomes in propensity-score matched “at risk” patients. J Endourol. 2018 Aug;32(8):717–723. doi: 10.1089/end.2018.0383.
   Web of Science ®Google Scholar
• Ben-Haim S, Sopov V, Stein A, et al. Kidney function after radical nephrectomy: assessment by quantitative SPECT of 99mTc-DMSA uptake by the kidneys. J Nucl Med. 2000;41:1025–1029.
   PubMed Web of Science ®Google Scholar
• Kasiske BL, Ma JZ, Louis TA, et al. Long-term effects of reduced renal mass in humans. Kidney Int. 1995;48:814–819.
   PubMed Web of Science ®Google Scholar
• Basturk T, Koc Y, Ucar Z, et al. Renal damage frequency in patients with solitary kidney and factors that affect progression. Int J Nephrol. 2015;2015:876907.
   PubMedGoogle Scholar
• Fergany AF, Saad IR, Woo L, et al. Open partial nephrectomy for tumor in a solitary kidney: experience with 400 cases. J Urol. 2006;175:1630–1633. discussion 1633.
   PubMed Web of Science ®Google Scholar
• Ching CB, Lane BR, Campbell SC, et al. Five to 10-year followup of open partial nephrectomy in a solitary kidney. J Urol. 2013;190:470–474.
   PubMed Web of Science ®Google Scholar
• Verhoest G, Patard JJ, Oger E, et al. Predictive factors of chronic kidney disease stage V after partial nephrectomy in a solitary kidney: a multi-institutional study. Urol Oncol. 2014;32(28):e21–6.
   Google Scholar
• Ghavamian R, Cheville JC, Lohse CM, et al. Renal cell carcinoma in the solitary kidney: an analysis of complications and outcome after nephron sparing surgery. J Urol. 2002;168:454–459.
   PubMed Web of Science ®Google Scholar
• Long JA, Bernhard JC, Bigot P, et al. Partial nephrectomy versus ablative therapy for the treatment of renal tumors in an imperative setting. World J Urol. 2017;35:649–656.
   PubMed Web of Science ®Google Scholar
• Mitchell CR, Atwell TD, Weisbrod AJ, et al. Renal function outcomes in patients treated with partial nephrectomy versus percutaneous ablation for renal tumors in a solitary kidney. J Urol. 2011;186:1786–1790.
   PubMed Web of Science ®Google Scholar
• Schmid M, Abd-El-Barr AE, Gandaglia G, et al. Predictors of 30-day acute kidney injury following radical and partial nephrectomy for renal cell carcinoma. Urol Oncol. 2014;32:1259–1266.
   PubMed Web of Science ®Google Scholar
• Schmid M, Krishna N, Ravi P, et al. Trends of acute kidney injury after radical or partial nephrectomy for renal cell carcinoma. Urol Oncol. 2016;34:293e1–293 e10.
   Web of Science ®Google Scholar
• Takagi T, Kondo T, Omae K, et al. Comparison of progression to end-stage renal disease requiring dialysis after partial or radical nephrectomy for renal cell carcinoma in patients with severe chronic kidney disease. Int Urol Nephrol. 2016;48:1421–1427.
   PubMed Web of Science ®Google Scholar
• Klarenbach S, Moore RB, Chapman DW, et al. Adverse renal outcomes in subjects undergoing nephrectomy for renal tumors: a population-based analysis. Eur Urol. 2011;59:333–339.
   PubMed Web of Science ®Google Scholar
• Yap SA, Finelli A, Urbach DR, et al. Partial nephrectomy for the treatment of renal cell carcinoma (RCC) and the risk of end-stage renal disease (ESRD). BJU Int. 2015;115:897–906.
   PubMed Web of Science ®Google Scholar
• Lin WY, Liang FW, Lu TH. Risk of end-stage renal disease after cancer nephrectomy in Taiwan: a nationwide population-based study. PLoS One. 2015;10:e0126965.
   PubMed Web of Science ®Google Scholar
• Chow WH, Dong LM, Devesa SS. Epidemiology and risk factors for kidney cancer. Nat Rev Urol. 2010;7:245–257.
   PubMed Web of Science ®Google Scholar
• Bretan PN Jr, Mp B, Hricak H, et al. Chronic renal failure: a significant risk factor in the development of acquired renal cysts and renal cell carcinoma. Case Reports and Review of the Literature. Cancer. 1986;57:1871–1879.
   Google Scholar
• Maisonneuve P, Agodoa L, Gellert R, et al. Cancer in patients on dialysis for end-stage renal disease: an international collaborative study. Lancet. 1999;354:93–99.
   PubMed Web of Science ®Google Scholar
• Yanik EL, Clarke CA, Snyder JJ, et al. Variation in cancer incidence among patients with esrd during kidney function and nonfunction intervals. J Am Soc Nephrol. 2016;27:1495–1504.
   PubMed Web of Science ®Google Scholar
• Wong G, Hayen A, Chapman JR, et al. Association of CKD and cancer risk in older people. J Am Soc Nephrol. 2009;20:1341–1350.
   PubMed Web of Science ®Google Scholar
• Lowrance WT, Ordonez J, Udaltsova N, et al. CKD and the risk of incident cancer. J Am Soc Nephrol. 2014;25:2327–2334.
   PubMed Web of Science ®Google Scholar
• Barlow LJ, Korets R, Laudano M, et al. Predicting renal functional outcomes after surgery for renal cortical tumours: A multifactorial analysis. BJU Int. 2010;106:489–492.
   PubMed Web of Science ®Google Scholar
• de Saint Aubert N, Audenet F, Mccaig F, et al. Nephron sparing surgery in tumours greater than 7 cm. Progres en Urologie. 2018;28:336–343.
   PubMed Web of Science ®Google Scholar
• Kalogirou C, Fender H, Muck P, et al. Long-term outcome of nephron-sparing surgery compared to radical nephrectomy for renal cell carcinoma >/=4 cm - A matched-pair single institution analysis. Urol Int. 2016;98:138–147.
   PubMed Web of Science ®Google Scholar
• Lau WK, Blute ML, Weaver AL, et al. Matched comparison of radical nephrectomy vs nephron-sparing surgery in patients with unilateral renal cell carcinoma and a normal contralateral kidney. Mayo Clin Proc. 2000;75:1236–1242.
   PubMed Web of Science ®Google Scholar
• An JY, Ball MW, Gorin MA, et al. Partial vs radical nephrectomy for T1-T2 renal masses in the elderly: comparison of complications, renal function, and oncologic outcomes. Urology. 2017;100:151–157.
   PubMed Web of Science ®Google Scholar
• Kim SH, Lee SE, Hong SK, et al. Incidence and risk factors of chronic kidney disease in korean patients with t1a renal cell carcinoma before and after radical or partial nephrectomy. Jpn J Clin Oncol. 2013;43:1243–1248.
   PubMed Web of Science ®Google Scholar
• Liek E, Wunderlich H, Elsebach K, et al. The overall survival benefit for patients with T1 renal cell carcinoma after nephron-sparing surgery depends on gender and age. Urol Int. 2018;100:309–316.
   PubMed Web of Science ®Google Scholar
• Zini L, Perrotte P, Capitanio U, et al. Radical versus partial nephrectomy: effect on overall and noncancer mortality. Cancer. 2009;115:1465–1471.
   PubMed Web of Science ®Google Scholar
• Wang DC, Plante K, Stewart T, et al. Comparison of survival for partial vs. radical nephrectomy in young patients with T1a renal cell carcinoma treated at commission on cancer-accredited facilities and influence of comorbidities on treatment choice. Urol Oncol Semin Orig Investig. 2017;35(660):e9–660.e15.
   Google Scholar
• Kim SP, Thompson RH, Boorjian SA, et al. Comparative effectiveness for survival and renal function of partial and radical nephrectomy for localized renal tumors: A systematic review and meta-analysis. J Urol. 2012;188:51–57.
   PubMed Web of Science ®Google Scholar
• Van Poppel H, Da Pozzo L, Albrecht W, et al. A prospective, randomised EORTC intergroup phase 3 study comparing the oncologic outcome of elective nephron-sparing surgery and radical nephrectomy for low-stage renal cell carcinoma. Eur Urol. 2011;59:543–552.
   PubMed Web of Science ®Google Scholar